ImmunityBio, Inc. (IBRX) — Analyst estimates
Consensus analyst estimates for ImmunityBio, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 71.30M | -0.07 | 1 |
| 2027 | 85.07M | -0.08 | 1 |
| 2028 | 352.1M | 0.13 | 1 |
| 2029 | 2.29B | 0.95 | 1 |
| 2030 | 3.12B | 1.41 | 1 |
Consensus analyst estimates by fiscal year.